Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: an ARIA-EAACI statement

Jean Bousquet*, Cezmi A. Akdis, Marek Jutel, Claus Bachert, Ludger Klimek, Ioana Agache, Ignacio J. Ansotegui, Anna Bedbrook, Sinthia Bosnic-Anticevich, G. Walter Canonica, Tomas Chivato, Alvaro A. Cruz, Wienczyslawa Czarlewski, Stefano Del Giacco, Hui Du, Joao A. Fonseca, Yadong Gao, Tari Haahtela, Karin Hoffmann-Sommergruber, Juan-Carlos IvancevichNikolaï Khaltaev, Edward F. Knol, Piotr Kuna, Desiree Larenas-Linnemann, Joaquim Mullol, Robert Naclerio, Ken Ohta, Yoshitaka Okamoto, Liam O’Mahony, Gabrielle L. Onorato, Nikos G. Papadopoulos, Oliver Pfaar, Boleslaw Samolinski, Jürgen Schwarze, Sanna Toppila-Salmi, Maria Teresa Ventura, Arunas Valiulis, Arzu Yorgancioglu, Torsten Zuberbier, Ruby Pawankar, the ARIA-MASK Study Group

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

116 Citations (Scopus)
Original languageEnglish
Pages (from-to)2440-2444
Number of pages5
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume75
Issue number10
DOIs
Publication statusPublished - 1 Oct 2020
Externally publishedYes

Cite this